Intracellular labile iron promotes firm adhesion of human monocytes to endothelium under flow and transendothelial migration. Iron and monocyte-endothelial cell interactions

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 369-375

  Kartikasari, Apriliana E R ^a   Visseren, Frank L J ^b   Marx, Joannes J M ^a   van Mullekom, Sanne ^a   Kats Renaud, J Henny van ^a   Asbeck, B Sweder van ^c   Ulfman, Laurien H ^b   Georgiou, Niki A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Vascular Medicine ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cytokines; Endothelium; Inflammation; Iron; Monocytes

Indexed keywords

ALPHA4 INTEGRIN; BETA2 INTEGRIN; CD31 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; IRON; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATORY DISEASE; IRON CHELATION; LEUKOCYTE ROLLING; MONOCYTE; NERVE DEGENERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; UPREGULATION;

ANTIGENS, CD18; ATHEROSCLEROSIS; CELL ADHESION; CELL MOVEMENT; CELL SEPARATION; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTEGRIN ALPHA4; IRON; MODELS, BIOLOGICAL; MONOCYTES; NEURODEGENERATIVE DISEASES;

EID: 67650873181     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.031     Document Type: Article

References (34)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-116
3. Han M.K., McLaughlin V.V., Criner G.J., and Martinez F.J. Pulmonary diseases and the heart. Circulation 116 (2007) 2992-3005
4. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57 (2008) 178-201
5. Liao F., Ali J., Greene T., and Muller W.A. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med 185 (1997) 1349-1357
6. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398 (1999) 718-723
7. Shamri R., Grabovsky V., Gauguet J.M., et al. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol 6 (2005) 497-506
8. Gu L., Okada Y., Clinton S.K., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Mol Cell 2 (1998) 275-281
9. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
10. Boisvert W.A., Santiago R., Curtiss L.K., and Terkeltaub R.A. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 101 (1998) 353-363
11. Kartikasari A.E., Georgiou N.A., and Marx J.J. Iron intake and cardiovascular disease. In: Arnoldi A. (Ed). Functional foods, cardiovascular disease and diabetes (2004), Woodhead Publishing Ltd., Abington, Cambridge, UK and CRC Press LLC, Boca Raton, FL, USA 99-125
12. Araujo J.A., Romano E.L., Brito B.E., et al. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 15 (1995) 1172-1180
13. Lee T.S., Shiao M.S., Pan C.C., and Chau L.Y. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 99 (1999) 1222-1229
14. Matthews A.J., Vercellotti G.M., Menchaca H.J., et al. Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1). J Surg Res 73 (1997) 35-40
15. Minqin R., Rajendran R., Pan N., et al. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic Biol Med 38 (2005) 1206-1211
16. Stadler N., Lindner R.A., and Davies M.J. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 24 (2004) 949-954
17. Roest M., van der Schouw Y.T., de Valk B., et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 100 (1999) 1268-1273
18. Kartikasari A.E., Georgiou N.A., Visseren F.L., et al. Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J 20 (2006) 353-355
19. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52 (1973) 2745-2756
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
21. Grootveld M., Bell J.D., Halliwell B., Aruoma O.I., Bomford A., and Sadler P.J. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 264 (1989) 4417-4422
22. Sakariassen K.S., Aarts P.A., de Groot P.G., Houdijk W.P., and Sixma J.J. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 102 (1983) 522-535
23. van Zanten H.G., Saelman E.U., Schut-Hese K.M., et al. Platelet adhesion to collagen type IV under flow conditions. Blood 88 (1996) 3862-3871
24. Kartikasari A.E., Georgiou N.A., de Geest M., et al. Iron enhances endothelial cell activation in response to Cytomegalovirus or Chlamydia pneumoniae infection. Eur J Clin Invest 36 (2006) 743-752
25. Saccani A., Saccani S., Orlando S., et al. Redox regulation of chemokine receptor expression. Proc Natl Acad Sci USA 97 (2000) 2761-2766
26. Kartikasari A.E., Georgiou N.A., Visseren F.L., et al. Intracellular labile iron modulates adhesion of human monocytes to human endothelial cells. Arterioscler Thromb Vasc Biol 24 (2004) 2257-2262
27. Zhang W.J., and Frei B. Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells. Free Radic Biol Med 34 (2003) 674-682
28. Weber K.S., von Hundelshausen P., Clark-Lewis I., Weber P.C., and Weber C. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol 29 (1999) 700-712
29. Ulfman L.H., Alblas J., van Aalst C.W., Zwaginga J.J., and Koenderman L. Differences in potency of CXC chemokine ligand 8-, CC chemokine ligand 11-, and C5a-induced modulation of integrin function on human eosinophils. J Immunol 175 (2005) 6092-6099
30. Le Lan C., Loreal O., Cohen T., et al. Redox active plasma iron in C282Y/C282Y hemochromatosis. Blood (2005)
31. Ahmed N.K., Hanna M., and Wang W. Nontransferrin-bound serum iron in thalassemia and sickle cell patients. Int J Biochem 18 (1986) 953-956
32. Kooistra M.P., Kersting S., Gosriwatana I., et al. Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. Eur J Clin Invest 32 Suppl 1 (2002) 36-41
33. Kohgo Y., Ikuta K., Ohtake T., Torimoto Y., and Kato J. Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance. World J Gastroenterol 13 (2007) 4699-4706
34. 2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am J Physiol Heart Circ Physiol 286 (2004) H1001-H1007